GeoVax Nasdaq Hearing Set for October 13; Stock Stays Listed During Appeal
GOVX is trading near its 52-week low of $0.45 (3.5% above the low).
Summary
GeoVax's Nasdaq delisting appeal hearing is scheduled for October 13, 2026. The hearing request stays delisting, keeping the stock trading on Nasdaq at least through that date.
Key Events · Legal and Risk Events · GOVX
-
Nasdaq Hearing Scheduled
Hearing before the Nasdaq Hearings Panel set for October 13, 2026 to appeal the delisting determination received August 27, 2026 for failing the $1.00 minimum bid price rule.
-
Delisting Stayed
The hearing request stays any suspension or delisting action pending the hearing and any extension period granted, so GOVX is expected to continue trading on Nasdaq at least through that period.
-
Compliance Plan
GeoVax intends to present its plan to regain and maintain compliance with Nasdaq listing standards at the hearing, including the proposed reverse stock split (1-for-10 to 1-for-25) pending shareholder approval.
-
Cash Runway Pressure
As of the last 10-Q (July 27, 2026), cash of $3.1 million funds operations only into September 2026, adding urgency to the listing appeal and financing efforts.
Analysis · GOVX · Life Sciences
A hearing date of October 13, 2026 has been secured before the Nasdaq Hearings Panel to appeal the delisting determination. The hearing request automatically stays any suspension or delisting action, meaning the stock will continue trading on Nasdaq at least through the hearing and any extension period granted. This is a critical lifeline for a company trading near its 52-week low with only $3.1 million in cash as of July 2026. Shareholder approval is also being sought for a reverse stock split to regain compliance with the $1.00 minimum bid price rule. The hearing outcome will determine whether GeoVax remains listed or faces delisting to the OTC market.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GOVX was trading at $0.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $0.45 to $18.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.